about
Emerging drugs for uveitisUveitis and gender: the course of uveitis in pregnancyThe effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocolManagement of noninfectious posterior uveitis with intravitreal drug therapyComparison of In Vivo Gene Expression Profiling of RPE/Choroid following Intravitreal Injection of Dexamethasone and Triamcinolone AcetonideInterventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.Local therapies for inflammatory eye disease in translation: past, present and futurePredictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography studyRisk of Ocular Hypertension in Adults with Noninfectious Uveitis.Ocular morbidity associated with intravitreal triamcinolone acetonide.Complications of intravitreal triamcinolone acetonide for macular edema and predictive factors for intraocular pressure elevationOutcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.Role of the retinal vascular endothelial cell in ocular diseaseFluocinolone acetonide intravitreal sustained release device--a new addition to the armamentarium of uveitic managementRisk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.Postoperative outcomes after fluocinolone acetonide implant surgery in patients with birdshot chorioretinitis and other types of posterior and panuveitis.Birdshot uveitis: current and emerging treatment optionsSuprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis.Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema.Dexamethasone intravitreal implant for the treatment of noninfectious uveitis.Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema.Emerging drugs for the treatment of uveitis.Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye.Sustained-release corticosteroid options.Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: a case report.Intravitreal triamcinolone for intraocular inflammation and associated macular edema.Intravitreal diclofenac for refractory uveitic cystoid macular edema.Intravitreal injection of triamcinolone acetonide into healthy rabbit eyes alters retinal function and morphology.Effect of intracameral triamcinolone acetonide on postoperative intraocular pressure after cataract surgery.Treatment of cystoid macular edema due to acute posterior multifocal placoid pigment epitheliopathy.Tomographic assessment of therapeutic response to uveitic macular oedema.Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.Comparison of Intravitreal Bevacizumab and Intravitreal Diclofenac in the Treatment of Diabetic Macular Edema: a 6-month Follow-up.A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis.Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis.Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema.Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis.Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014].Raised intraocular pressure following Intravitreal Triamcinolone Acetonide in diabetic versus non-diabetic patients
P2860
Q24630848-B87BB93E-AF64-409D-823F-00C56C59BC25Q26864267-A4B0A6FF-4FD2-499C-B781-A378F5590A57Q28068067-9FCA6A49-465F-41C1-81E6-F31E63FE7805Q28074741-20B42AF1-B063-4A67-8FE8-D67AF66A07ECQ28383760-66014CBD-7BEA-4882-9E4A-CBA488AAFDBDQ34786343-A0571D0D-2C43-4222-8CA9-8569BDE30F8AQ34892662-145F8AE8-6ADB-46D4-8AA2-0F1F0B6D305AQ35956280-EB25BA62-F1CC-4307-AF5C-B110F36E3001Q36354205-0A1FC9A2-5F57-4231-8005-8FFDC77802F6Q36482537-92E93684-DF48-4490-9F45-5A12CDBCE086Q36490459-4A2A24D6-0EA9-4E86-ACAC-19E3BBBA3439Q36611020-85A27362-4C10-44E6-A162-F1C4A291BD96Q36919959-1F05AD32-1ACB-4E64-8967-746B60DD2ECAQ36920430-2C6666A7-D13F-45F7-A89E-571E2DD4BAC5Q37038644-2CE63A6E-4A26-4D5E-AD81-A352B835FA90Q37310082-284071FB-D481-44C3-9BAC-29C2EA53659FQ37412317-67D5255C-745D-4F3F-9C0A-B6632B9A907BQ37503170-400CE131-8BE5-448C-BA36-8A89C976465BQ37905833-A3FC7256-8DFF-4C31-98D0-4F1C4F172C89Q37964659-95C124A3-3268-4C08-A33C-3C4B44A338CDQ38092035-5CE2A840-FADE-493D-A3D9-88818384F536Q38166016-0126F201-F0DA-4DF4-9536-BC3883523C1EQ38211433-187AD8B4-DA75-42F1-9275-6BBD11E0F1E5Q38241548-F8B77471-7DD9-4A15-9397-2D51F42E56FFQ39457673-7804AE85-9AB5-4258-BEE5-94CD3B4D7D56Q43096392-17B8A223-5633-4788-81F1-B7C46AF41729Q43116414-61BF11BE-2F6B-4465-933C-9383418F218FQ45166553-7408F5DE-569F-41AE-BA85-03AFA7EFDBD7Q45933318-9ACACD54-15ED-4EB2-8E41-BAAC1E5E97F6Q46671352-262C17E9-CD75-4373-9E06-ABB99485434CQ46903671-7FDF41C5-3966-4CE3-A865-813B698F8981Q46903674-C4B07D65-5396-4B83-A7F8-755CD388DB7DQ49385210-DA8792DE-336A-49CD-BC60-002326B18BBDQ49395944-AC28428B-574A-41FC-B436-C65B5B3077D3Q50789266-379CA278-1C01-45D4-AEB7-3104848DF463Q53599525-4EACF3BB-ED62-489D-8E1B-9074A28DF7C7Q54232726-D4B642B6-7A02-4C35-AA86-7E89912F585BQ54313925-253CD41D-406D-46B2-8D0A-944FC7E8FD57Q54641208-2BA63FC1-7415-49B7-A693-1B9B734D302DQ57823024-0025895D-7A6D-41A2-AAB7-2C46DE0A6CDF
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Outcome of intravitreal triamcinolone in uveitis.
@en
Outcome of intravitreal triamcinolone in uveitis.
@nl
type
label
Outcome of intravitreal triamcinolone in uveitis.
@en
Outcome of intravitreal triamcinolone in uveitis.
@nl
prefLabel
Outcome of intravitreal triamcinolone in uveitis.
@en
Outcome of intravitreal triamcinolone in uveitis.
@nl
P2093
P1433
P1476
Outcome of intravitreal triamcinolone in uveitis.
@en
P2093
Howesen Kok
Nicholas Maycock
Peter McCluskey
Susan Lightman
P304
P356
10.1016/J.OPHTHA.2005.06.009
P577
2005-09-19T00:00:00Z